
Please try another search
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Name | Age | Since | Title |
---|---|---|---|
Cameron Reynolds | 53 | 2010 | Founder, CEO, President & Director |
Mark Eccleston | 53 | 2011 | Member of Scientific Advisory Board |
Alan Colman | 75 | 2011 | Member of Scientific Advisory Board & Independent Non Executive Director |
Mickie Henshall | 52 | 2022 | Independent Director |
Phillip Barnes | 62 | 2019 | Independent Non-Executive Director |
Timothy Fan | - | 2022 | Member of Scientific Advisory Board |
Axel Imhof | - | 2019 | Member of Scientific Advisory Board |
Ethel Rubin | - | 2024 | Independent Director |
Kim Nguyen | 47 | 2021 | Independent Director |
Alexander Hoffmann | - | 2023 | Member of Scientific Advisory Board |
Timothy I. Still | 59 | 2024 | Independent Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review